Cargando…

Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial

BACKGROUND: Small studies suggest peanut oral immunotherapy (OIT) might be effective in the treatment of peanut allergy. We aimed to establish the efficacy of OIT for the desensitisation of children with allergy to peanuts. METHODS: We did a randomised controlled crossover trial to compare the effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anagnostou, Katherine, Islam, Sabita, King, Yvonne, Foley, Loraine, Pasea, Laura, Bond, Simon, Palmer, Chris, Deighton, John, Ewan, Pamela, Clark, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255069/ https://www.ncbi.nlm.nih.gov/pubmed/24485709 http://dx.doi.org/10.1016/S0140-6736(13)62301-6

Ejemplares similares

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
por: Chebar Lozinsky, Adriana, et al.
Publicado: (2020)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin
por: Matheu, Victor, et al.
Publicado: (2005)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Messaging Fatigue and Desensitisation to Information During Pandemic
por: Koh, Philip Kheng-Keah, et al.
Publicado: (2020)

Peanut Allergy: An Overview
por: Al-Ahmed, Nasser, et al.
Publicado: (2008)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children
por: Burman, Janne, et al.
Publicado: (2022)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Developing Therapies for Peanut Allergy
por: Bublin, Merima, et al.
Publicado: (2014)

2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review
por: Nurmatov, Ulugbek, et al.
Publicado: (2013)

The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity
por: McCann, William, et al.
Publicado: (2021)

Efficacy and safety of oral immunotherapy for peanut allergy: a pilot study in Singaporean children
por: Zhong, Youjia, et al.
Publicado: (2018)

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice
por: Portnoy, Jay, et al.
Publicado: (2022)

Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model
por: Liu, Manman, et al.
Publicado: (2022)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Adhesion molecules in experimental peanut allergy
por: Bennett, Jami, et al.
Publicado: (2010)

sIgE to peanut components does not accurately predict the severity of allergy in subjects suspected of peanut allergy
por: Klemans, Rob, et al.
Publicado: (2015)

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017)

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy
por: Wright, Benjamin L., et al.
Publicado: (2018)

Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
por: LaHood, Nicole A., et al.
Publicado: (2023)

Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study)
por: Loke, Paxton, et al.
Publicado: (2021)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible
por: Glaumann, Susanne, et al.
Publicado: (2013)

Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
por: Cherkaoui, Sabrine, et al.
Publicado: (2015)

Successful cholecalciferol desensitisation in a case of delayed hypersensitivity
por: Anantharajah, Anthea, et al.
Publicado: (2019)

Desensitisation of Notch signalling through dynamic adaptation in the nucleus
por: Viswanathan, Ranjith, et al.
Publicado: (2021)

Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status
por: Asai, Yuka, et al.
Publicado: (2013)

Allergy to Peanuts imPacting Emotions And Life (APPEAL): the impact of peanut allergy on children, adolescents, adults and caregivers in France
por: Couratier, Pascale, et al.
Publicado: (2020)

IgG(4) inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens
por: Santos, Alexandra F., et al.
Publicado: (2015)

A Practical, Stepwise Approach to Peanut Oral Immunotherapy in Clinical Practice: Benefits and Risks
por: Anagnostou, Aikaterini
Publicado: (2021)

The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Tice, Jeffrey A., et al.
Publicado: (2020)

Immunotherapy using algal‐produced Ara h 1 core domain suppresses peanut allergy in mice
por: Gregory, James A., et al.
Publicado: (2016)

The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults
por: Mäntylä, Jarkko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_77n7lp3p0da8i1ic3f4l450jlm